Psoriatic Arthritis (PsA) was typically diagnosed and managed via clinical evaluation, physical examination, and basic imaging techniques. However, digital technologies are transforming PsA care, paving the way to digital rheumatology. This paper presents the existing clinical PsA landscape, highlight the PsA patients' interaction with the digital world, and showcasing the novel iPROLEPSIS approach. The latter is reinforcing digital rheumatology through PsA key drivers, supporting personalized PsA risk prediction, and improving early-stage PsA detection. Furthermore, it is enabling precise PsA treatment strategies and digital therapeutics within a novel digital health ecosystem. See more.